RESULT_COUNT: 195,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
GRFS,GRFS:UW,BBG001QMCL19,"ETFs with exposure to Grifols SA : October 10, 2017",2017-10-10 15:29:58 +0000,http://finance.yahoo.com/r/fbd653db-10c2-35f1-8967-45a6240b9874/etfs-with-exposure-to-grifols-sa-october-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Grifols SA Here are 5 ETFs with the largest exposure to GRFS-US. Comparing the performance and risk of Grifols SA with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA :GRFS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 9, 2017",2017-10-09 13:51:53 +0000,http://finance.yahoo.com/r/6ed043fd-161e-3617-bc7d-6553a77db2bf/grifols-sa-grfs-us-earnings-analysis-q2-2017-by-the-numbers-october-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Grifols SA reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 1,264.20 million, Net Earnings of USD 160.84 million. Gross margins widened from 45.26% to 47.95% compared to the same period last year, operating (EBITDA) margins now 29.92% from 27.31%. Change in operating cash ... Read more
<b>(Read more...)</b>"
GRFS,GRFS:UW,BBG001QMCL19,Should Value Investors Consider Grifols (GRFS) Stock Now?,2017-09-20 15:43:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7vxUSsKfayo/should-value-investors-consider-grifols-grfs-stock-now-cm848375,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
GRFS,GRFS:UW,BBG001QMCL19,Should Value Investors Consider Grifols (GRFS) Stock Now?,2017-09-20 13:30:01 +0000,https://finance.yahoo.com/news/value-investors-consider-grifols-grfs-133001588.html?.tsrc=rss,Is Grifols (GRFS) a great pick from the value investor&apos;s perspective right now? Read on to know more.
GRFS,GRFS:UW,BBG001QMCL19,3 Pharma/Biotech Sector Bargains for a Healthy Portfolio,2017-09-13 17:36:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k2XMQxazGSY/3-pharmabiotech-sector-bargains-for-a-healthy-portfolio-cm845231,After a lackluster performance in 2016 the drug biotech sector has shown promise since the beginning of 2017 With no major announcement related to drug pricing control since Trump s election as President investors are breathing a sigh of relief Drug pricing controversy was one the major
GRFS,GRFS:UW,BBG001QMCL19,3 Pharma/Biotech Sector Bargains for a Healthy Portfolio,2017-09-13 15:25:03 +0000,https://finance.yahoo.com/news/3-pharma-biotech-sector-bargains-152503838.html?.tsrc=rss,"The biotech sector has turned around after its dismal performance in 2016 as uncertainty surrounding drug pricing control subsides. A few stocks are however still undervalued, which may gain going ahead."
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Advance as Pharma Stocks See Mixed Fortunes,2017-09-06 15:29:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jdVtLRscRVk/european-adrs-advance-as-pharma-stocks-see-mixed-fortunes-cm841661,American depository receipts of European stocks were 0 4 higher at 134 99 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 4 higher at 134 99 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Gainers
GRFS,GRFS:UW,BBG001QMCL19,Grifols Shows Market Leadership With Jump To 82 RS Rating,2017-09-06 07:00:00 +0000,http://finance.yahoo.com/r/f83772af-2ca5-3e7d-89b8-78f2a0094b37/grifols-shows-market-leadership-with-jump-to-82-rs-rating?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Grifols shows improving technical performance.
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Move Lower in Wednesday Trading,2017-08-30 15:49:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uBujS36K8Mo/european-adrs-move-lower-in-wednesday-trading-cm839186,American depository receipts of European stocks were trading 0 16 lower at 133 96 on the Bank of New York Mellon Europe ADR Index on Wednesday American depository receipts of European stocks were trading 0 16 lower at 133 96 on the Bank of New York Mellon Europe ADR Index on Wednesday
GRFS,GRFS:UW,BBG001QMCL19,Grifols Is a Leader in High-Demand Plasma,2017-08-29 16:31:31 +0000,https://finance.yahoo.com/news/grifols-leader-high-demand-plasma-163131881.html?.tsrc=rss,The Spanish company is the number 2 operator of plasma centers in the world
GRFS,GRFS:UW,BBG001QMCL19,Stocks Flashing Renewed Technical Strength: Grifols,2017-08-28 07:00:00 +0000,http://finance.yahoo.com/r/afe8aadd-5708-3883-95be-36f1d623e858/stocks-flashing-renewed-technical-strength-grifols?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Grifols shows improving technical performance.
GRFS,GRFS:UW,BBG001QMCL19,Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces,2017-08-22 12:00:00 +0000,https://finance.yahoo.com/news/grifols-phocus-rx-pharmacy-workflow-120000596.html?.tsrc=rss,"Phocus Rx® is Live with Bidirectional Interfaces with Three of the Top Five Hospital Information Systems in the US BARCELONA, Spain , Aug. 22, 2017 /PRNewswire/ -- Phocus Rx ® enhances safety and improves ..."
GRFS,GRFS:UW,BBG001QMCL19,Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol,2017-08-01 12:00:00 +0000,https://finance.yahoo.com/news/select-american-red-cross-blood-120000368.html?.tsrc=rss,- American Red Cross is testing selected donations collected in areas of the U.S. that are endemic for the tick known to carry the Babesia parasite - The data collected will be used in the submission process ...
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Fractionally Higher as Banks See Mixed Fortunes,2017-07-31 15:34:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K-XJIcKT8VE/european-adrs-fractionally-higher-as-banks-see-mixed-fortunes-cm824277,American depository receipts of European stocks were 0 1 higher at 137 31 on the Bank of New York Mellon Europe ADR Index on Monday morningAmerican depository receipts of European stocks were 0 1 higher at 137 31 on the Bank of New York Mellon Europe ADR Index on Monday morning Gainers
GRFS,GRFS:UW,BBG001QMCL19,"Gladstone Capital Management LLP Buys Activision Blizzard Inc, Charter Communications Inc, ...",2017-07-06 12:43:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CitlYH6HaZ0/gladstone-capital-management-llp-buys-activision-blizzard-inc-charter-communications-inc-cm812236,Gladstone Capital Management LLP Added Positions ATVI CHTR TWTR Reduced Positions SQ QCOM GOOGL GRFS Sold Out PCLN ZNGA BBD PTC STX Added Positions ATVI CHTR TWTR Added Positions ATVI CHTR
GRFS,GRFS:UW,BBG001QMCL19,Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples,2017-06-22 19:11:00 +0000,https://finance.yahoo.com/news/grifols-continues-strengthen-diagnostic-division-191100161.html?.tsrc=rss,"BARCELONA, Spain, June 22, 2017 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, and a leader in the development of innovative diagnostic solutions, is expanding its Texas-based Clinical Diagnostics Laboratory menu by launching therapeutic drug monitoring testing services.  As the standard of care changes towards individualized patient care in diseases such as inflammatory bowel diseases, the clinicians' demand for monitoring biologic drugs is growing."
GRFS,GRFS:UW,BBG001QMCL19,When &apos;New&apos; Means A Stock Hasn&apos;t Led The Market In A While,2017-06-21 19:48:58 +0000,http://finance.yahoo.com/r/e0a7069c-7fac-39fd-9f51-31600f86f9d7/sometimes-new-means-the-stock-hasnt-been-around-for-a-while?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene and Grifols are former leaders, but enough time has passed to give them a new shine."
GRFS,GRFS:UW,BBG001QMCL19,Interesting GRFS Put And Call Options For February 2018,2017-06-21 16:25:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ivn7RAP4VAA/interesting-grfs-put-and-call-options-for-february-2018-cm806291,Investors in Grifols SA Barcelona Symbol GRFS saw new options become available this week for the February 2018 expiration One of the key data points that goes into the price an option buyer is willing to pay is the time value so with 240 days until expiration the newly available
GRFS,GRFS:UW,BBG001QMCL19,Should Value Investors Consider Grifols (GRFS) Stock Right Now?,2017-06-16 16:11:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kmp6BlmFYFU/should-value-investors-consider-grifols-grfs-stock-right-now-cm804394,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Move Higher in Friday Trading,2017-06-16 15:46:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ePzzRNatu8w/european-adrs-move-higher-in-friday-trading-cm804431,American depository receipts of European stocks were trading 0 45 higher at 132 87 on the Bank of New York Mellon Europe ADR Index on Friday American depository receipts of European stocks were trading 0 45 higher at 132 87 on the Bank of New York Mellon Europe ADR Index on Friday In
GRFS,GRFS:UW,BBG001QMCL19,Should Value Investors Consider Grifols (GRFS) Stock Right Now?,2017-06-16 13:55:01 +0000,https://finance.yahoo.com/news/value-investors-consider-grifols-grfs-135501980.html?.tsrc=rss,Is Grifols a great pick from the value investor&apos;s perspective right now? Read on to know more.
GRFS,GRFS:UW,BBG001QMCL19,Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement,2017-06-12 08:00:00 +0000,https://finance.yahoo.com/news/grifols-beckman-coulter-enter-exclusive-080000839.html?.tsrc=rss,"BARCELONA, June 12, 2017 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the world's leading producers of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, and Beckman Coulter Inc., a leading provider of innovative, efficient and reliable diagnostics solutions, have entered into an exclusive, long-term agreement for the global distribution of Grifols' hemostasis instruments, reagents and consumables.  ""Grifols continues to execute its strategy in growing the Specialty Diagnostics line.  ""Beckman Coulter's long-term partnership with Grifols expands our extensive diagnostic product offering and further supports our position as a partner of choice with hospitals and clinical laboratories across the world,"" stated Arnd Kaldowski, President of Beckman Coulter Diagnostics."
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA : GRFS-US: Dividend Analysis : June 01st, 2017 (record date) : By the numbers : May 31, 2017",2017-05-31 15:02:02 +0000,http://finance.yahoo.com/r/5164833d-007a-3411-bf94-343f0e9e4bf8/grifols-sa-grfs-us-dividend-analysis-june-01st-2017-record-date-by-the-numbers-may-31-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Our analysis is based on comparing Grifols SA with the following peers – Baxter International Inc., China Biologic Products, Inc., Amgen Inc., China Cord Blood Corporation, Kimberly-Clark Corporation, Johnson & Johnson, Cord Blood America, Inc., Aradigm Corporation and Mylan N.V. (BAX-US, CBPO-US, AMGN-US, CO-US, KMB-US, JNJ-US, CBAI-US, ARDM-US and MYL-US). Dividend ... Read more
<b>(Read more...)</b>"
GRFS,GRFS:UW,BBG001QMCL19,"Tuesday's ETF Movers: VGK, IHF",2017-05-16 17:15:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U2qHZ31aNVY/tuesdays-etf-movers-vgk-ihf-cm790025,In trading on Tuesday the Vanguard FTSE Europe ETF is outperforming other ETFs up about 0 8 on the day Components of that ETF showing particular strength include shares of Vodafone Group up about 3 8 and shares of Grifols up about 2 6 on the day And underperforming other ETFs
GRFS,GRFS:UW,BBG001QMCL19,"Hologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents",2017-05-10 20:45:17 +0000,http://finance.yahoo.com/r/597df2ae-1f9e-3aba-a842-f25fcc9c5ca1/hologic-smashes-fiscal-q2-sales-views-beats-on-profit-by-4-cents?src=A00220&yptr=yahoo&.tsrc=rss,"Hologic crushed Wall Street&apos;s fiscal second-quarter revenue and profit expectations late Wednesday, led by double-digit growth."
GRFS,GRFS:UW,BBG001QMCL19,Investigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US,2017-05-09 14:00:00 +0000,http://finance.yahoo.com/news/investigational-drug-application-now-effective-140000572.html?.tsrc=rss,"BARCELONA, Spain, May 9, 2017 /PRNewswire/ --  Test is designed to detect the presence in whole blood, of the four clinically relevant species of Babesia ( B. microti, B. duncani, B. divergens, and B. ..."
GRFS,GRFS:UW,BBG001QMCL19,"VIVUS (VVUS) Loss Narrower than Expected, Revenues Up Y/Y",2017-05-04 16:13:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Xngi1ta8FI/vivus-vvus-loss-narrower-than-expected-revenues-up-yy-cm784191,VIVUS Inc VVUS reported a loss of 1 cent per share in the first quarter of 2017 which was narrower than a loss of 12 cents in the year ago period as well as the Zacks Consensus Estimate of a loss of 13 cents Shares of the biotech company rose almost 3 in aftermarket hours on
GRFS,GRFS:UW,BBG001QMCL19,"VIVUS (VVUS) Loss Narrower than Expected, Revenues Up Y/Y",2017-05-04 14:37:02 +0000,http://finance.yahoo.com/news/vivus-vvus-loss-narrower-expected-143702222.html?.tsrc=rss,"VIVUS Inc. (VVUS) reported a loss of 1 cent per share in the first quarter of 2017, which was narrower than a loss of 12 cents in the year-ago period as well as the Zacks Consensus Estimate of a loss of 13 cents"
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Fractionally Higher as Banking Stocks Edge Forward,2017-05-01 15:26:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ARMSGTDWIvU/european-adrs-fractionally-higher-as-banking-stocks-edge-forward-cm782024,American depository receipts of European stocks were 0 1 higher at 129 79 on the Bank of New York Mellon Europe ADR Index on Monday morning American depository receipts of European stocks were 0 1 higher at 129 79 on the Bank of New York Mellon Europe ADR Index on Monday morning Gainers
GRFS,GRFS:UW,BBG001QMCL19,Akebia Therapeutics (AKBA) Shows Strength: Stock Up 5.8%,2017-04-28 13:27:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YvzULtNSN00/akebia-therapeutics-akba-shows-strength-stock-up-58-cm781030,Akebia Therapeutics Inc AKBA was a big mover last session as the company saw its shares rise almost 6 on the day The move came after the company signed an expanded agreement with Otsuka Pharmaceutical on its anemia drug Also this led to far more shares changing hands than in a
GRFS,GRFS:UW,BBG001QMCL19,"Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View",2017-04-27 22:28:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NuUrzVzDjnU/glaxo-gsk-reports-in-line-q1-earnings-reiterates-view-cm780722,GlaxoSmithKline plc s GSK first quarter results came roughly in line with expectations Glaxo reported first quarter 2017 core earnings of 62 cents per American Depositary Share ADS in line with the Zacks Consensus Estimate Earnings were up 9 year over year at constant exchange rates
GRFS,GRFS:UW,BBG001QMCL19,"Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View",2017-04-27 20:37:08 +0000,http://finance.yahoo.com/news/glaxo-gsk-reports-line-q1-203708194.html?.tsrc=rss,"GlaxoSmithKline plc&apos;s (GSK) first quarter results came roughly in line with expectations. Glaxo reported first-quarter 2017 core earnings of 62 cents per American Depositary Share (ADS), in line with the Zacks Consensus Estimate."
GRFS,GRFS:UW,BBG001QMCL19,"Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View",2017-04-27 17:31:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k30rc6ns-qs/celgene-celg-tops-on-q1-earnings-sales-miss-raises-view-cm780499,Celgene Corporatio n CELG reported first quarter 2017 earnings of 1 53 per share including share based compensation expense and tax adjustments beating the Zacks Consensus Estimate of 1 47 but up from 1 18 per share in the year ago quarter Celgene s share price movement shows
GRFS,GRFS:UW,BBG001QMCL19,"Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View",2017-04-27 15:11:03 +0000,http://finance.yahoo.com/news/celgene-celg-tops-q1-earnings-151103437.html?.tsrc=rss,"Celgene&apos;s (CELG) first-quarter results were mixed, with the company beating on earnings but missing on sales."
GRFS,GRFS:UW,BBG001QMCL19,Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility,2017-04-24 12:00:00 +0000,http://finance.yahoo.com/news/grifols-strengthens-position-global-provider-120000325.html?.tsrc=rss,"EMERYVILLE, Calif., April  24, 2017 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company with a history of more than 75 years of improving people's health and well-being and a leader in the development of innovative diagnostic solutions, announces that it has restated its 2005 agreement with OraSure Technologies (""OraSure""), a leader in point-of-care diagnostic tests.  The test is FDA approved for qualitatively detecting hepatitis C virus antibodies in whole blood obtained through the use of a fingerstick or venipuncture."
GRFS,GRFS:UW,BBG001QMCL19,AbbVie (ABBV) Presents Positive Data on HCV Combination Drug,2017-04-21 17:03:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_JLxlqB4dn8/abbvie-abbv-presents-positive-data-on-hcv-combination-drug-cm777134,AbbVie Inc ABBV announced that data from two phase III studies EXPEDITION 1 and ENDURANCE 3 evaluating its investigational pan genotypic regimen of glecaprevir pibrentasvir G P for all genotypes of Hepatitis C virus HCV were presented at The International Liver Congress
GRFS,GRFS:UW,BBG001QMCL19,Nivalis' (NVLS) Shares Down After Merger Deal with Alpine,2017-04-20 17:05:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EKnvaJtcNb0/nivalis-nvls-shares-down-after-merger-deal-with-alpine-cm776519,The announcement of Nivalis Therapeutics Inc s NVLS merger agreement with a privately held biotechnology company Alpine Immune Sciences Inc failed to excite investors Nivalis fell more than 10 on Wednesday following the announcement This all stock transaction is expected to be
GRFS,GRFS:UW,BBG001QMCL19,"Zacks.com featured highlights: Arbor Realty, Commercial Vehicle Group, Grifols, S.A., Match Group and Xcerra",2017-04-20 16:06:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lZiouiH4WYA/zackscom-featured-highlights-arbor-realty-commercial-vehicle-group-grifols-sa-match-group-and-xcerra-cm776468,For Immediate Release Chicago IL April 20 2017 Stocks in this week s article include 160 Arbor Realty NYSE ABR Free Report Commercial Vehicle Group NASDAQ CVGI Free Report Grifols S A NASDAQ GRFS Free Report Match Group NASDAQ MTCH Free
GRFS,GRFS:UW,BBG001QMCL19,Nivalis&apos; (NVLS) Shares Down After Merger Deal with Alpine,2017-04-20 14:30:02 +0000,http://finance.yahoo.com/news/nivalis-apos-nvls-shares-down-143002400.html?.tsrc=rss,"The announcement of Nivalis Therapeutics, Inc.&apos;s (NVLS) merger agreement with a privately-held biotechnology company, Alpine Immune Sciences, Inc. failed to excite investors."
GRFS,GRFS:UW,BBG001QMCL19,GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1%,2017-04-20 14:06:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/--qo6fSsXIY/genocea-biosciences-gnca-catches-eye-stock-gains-71-cm776295,GENOCEA BIOSCIENCES INC GNCA was a big mover last session as its shares rose over 7 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up over 19 in the
GRFS,GRFS:UW,BBG001QMCL19,GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1%,2017-04-20 12:15:12 +0000,http://finance.yahoo.com/news/genocea-biosciences-gnca-catches-eye-121512438.html?.tsrc=rss,"GENOCEA BIOSCIENCES, INC. (GNCA) moved big last session, as its shares rose over 7% on the day."
GRFS,GRFS:UW,BBG001QMCL19,How to Uncover Institutional Buying,2017-04-19 21:04:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eeCidwC-V3Y/how-to-uncover-institutional-buying-cm776145,One of the best ways to find stocks on the move that are grabbing the attention of investors is to screen for stocks with increasing volume This is because increased volume shows investor interest As more investors buy the stock the stock s price should go higher But the individual
GRFS,GRFS:UW,BBG001QMCL19,How to Uncover Institutional Buying,2017-04-19 18:06:06 +0000,http://finance.yahoo.com/news/uncover-institutional-buying-180606278.html?.tsrc=rss,How to Uncover Institutional Buying
GRFS,GRFS:UW,BBG001QMCL19,Can young blood pump new life into treatments for diseases of aging?,2017-04-19 17:32:40 +0000,http://finance.yahoo.com/r/ca497d5d-df41-383b-9cd9-d3def3c16a99/aging-stanford-young-blood-grifols-grfs-alkahest.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Young blood loaded with a particular protein, which is less plentiful as people age, could rejuvenate learning and memory, Stanford University researchers said in a paper released today.  It would take even longer to make drugs that mimic the protein.  Ultimately, San Carlos' Alkahest Inc., which has rights to license the research, and Barcelona-based Grifols S.A. (GRFS) could market treatments aimed at age-associated declines in learning skills and memory, but not necessarily targeting memory-robbing Alzheimer's disease."
GRFS,GRFS:UW,BBG001QMCL19,AMAG Files for FDA Approval of Subcutaneous Form of Makena,2017-04-18 17:05:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nqXnlP1MjDM/amag-files-for-fda-approval-of-subcutaneous-form-of-makena-cm775338,AMAG Pharmaceuticals Inc AMAG announced the submission of a supplemental New Drug Application sNDA to the FDA for the subcutaneous auto injector form of its marketed drug Makena in the U S 160 Makena is currently approved as an intramuscular IM injection to reduce the risk of
GRFS,GRFS:UW,BBG001QMCL19,Ohr Pharmaceutical (OHRP) Jumps: Stock Adds 15% in Session,2017-04-18 15:08:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xq0kfzyJ4Ek/ohr-pharmaceutical-ohrp-jumps-stock-adds-15-in-session-cm775181,Ohr Pharmaceutical Inc OHRP was a big mover last session as its shares rose 15 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above the volatile price range
GRFS,GRFS:UW,BBG001QMCL19,Infinity Pharmaceuticals (INFI) Looks Good: Stock Jumps 19%,2017-04-18 13:58:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fuDt3kshnzs/infinity-pharmaceuticals-infi-looks-good-stock-jumps-19-cm775184,Infinity Pharmaceuticals Inc INFI was a big mover last session as the company saw its shares rise over 19 on the day The move came on solid volume with far more shares changing hands than in a normal session This reverses the recent trend for the company as the stock is now down nearly
GRFS,GRFS:UW,BBG001QMCL19,Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program,2017-04-17 13:00:00 +0000,http://finance.yahoo.com/news/grifols-donates-140-million-international-130000484.html?.tsrc=rss,"BARCELONA, Spain, April 17, 2017 /PRNewswire/ -- Today, Grifols, S.A. (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS) announced that it will donate a minimum of 140 million international units (IU) of blood clotting factor medicines (Factor VIII) to the World Federation of Hemophilia (WFH) Humanitarian Aid Program over the next five (5) years.  This announcement is a continuation of the Company's three-year commitment from 2014, bringing the total humanitarian aid commitment to more than 200M IU of Factor VIII over eight years."
GRFS,GRFS:UW,BBG001QMCL19,Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program,2017-04-17 13:00:00 +0000,http://finance.yahoo.com/news/grifols-donates-140-million-international-130000268.html?.tsrc=rss,"BARCELONA, Spain, April 17, 2017 /PRNewswire/ -- Today, Grifols, S.A. (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS) announced that it will donate a minimum of 140 million international units (IU) of blood clotting factor medicines (Factor VIII) to the World Federation of Hemophilia (WFH) Humanitarian Aid Program over the next five (5) years.  This announcement is a continuation of the Company's three-year commitment from 2014, bringing the total humanitarian aid commitment to more than 200M IU of Factor VIII over eight years."
GRFS,GRFS:UW,BBG001QMCL19,"Wednesday's ETF Movers: FBT, XME",2017-04-12 18:54:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u-bxD2v07bc/wednesdays-etf-movers-fbt-xme-cm773414,In trading on Wednesday the First Trust NYSE Arca Biotechnology Index Fund ETF FBT is outperforming other ETFs up about 0 7 on the day Components of that ETF showing particular strength include shares of Neurocrine Biosciences NBIX up about 23 7 and shares of Grifols GRFS
GRFS,GRFS:UW,BBG001QMCL19,TherapeuticsMD Falls on Likely Delay in TX-004HR Approval,2017-04-12 13:57:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uyvOOVBQTw0/therapeuticsmd-falls-on-likely-delay-in-tx-004hr-approval-cm773181,Shares of TherapeuticsMD Inc TXMD have declined almost 25 since Monday when it received a letter from the FDA identifying deficiencies in the new drug application NDA for its dyspareunia drug TX 400HR filed last July The company s shares have slightly underperformed the Zacks
GRFS,GRFS:UW,BBG001QMCL19,Galectin Therapeutics (GALT) Looks Good: Stock Jumps 16.7%,2017-04-10 13:56:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mDqL2WnWdEA/galectin-therapeutics-galt-looks-good-stock-jumps-167-cm772093,Galectin Therapeutics Inc GALT was a big mover last session as the company saw its shares rise nearly 17 on the day The move came after the company received positive FDA feedback that it would be able to continue operations through the rest of the year This led to far more shares
GRFS,GRFS:UW,BBG001QMCL19,"Amgen Files for Xgeva Label Expansion, To Include Myeloma",2017-04-05 16:55:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gkx8_sYWCNc/amgen-files-for-xgeva-label-expansion-to-include-myeloma-cm770231,Amgen Inc AMGN recently announced that it has submitted a supplemental Biologics License Application sBLA to the FDA to expand the label of its key drug Xgeva Xgeva is currently approved for the prevention of skeletal related events SREs in solid tumors in patients with bone
GRFS,GRFS:UW,BBG001QMCL19,"Amgen Files for Xgeva Label Expansion, To Include Myeloma",2017-04-05 15:20:03 +0000,http://finance.yahoo.com/news/amgen-files-xgeva-label-expansion-152003687.html?.tsrc=rss,"Amgen, Inc. (AMGN) recently announced that it has submitted a supplemental Biologics License Application (sBLA) to the FDA to expand the label of its key drug, Xgeva."
GRFS,GRFS:UW,BBG001QMCL19,Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk,2017-04-04 15:28:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-0yAyv1_-I/sanofis-sny-diabetes-drug-toujeo-lowers-hypoglycemia-risk-cm769559,Sanofi SNY presented data from a real world observational study which showed that when type 2 diabetes patients on basal insulin switched to its diabetes drug Toujeo it led to a significant reduction in risk of hypoglycemia without compromising blood sugar control The study compared
GRFS,GRFS:UW,BBG001QMCL19,Sanofi&apos;s (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk,2017-04-04 13:19:01 +0000,http://finance.yahoo.com/news/sanofi-apos-sny-diabetes-drug-131901719.html?.tsrc=rss,"A real-world observational study showed that when type 2 diabetes patients on basal insulin switched to Toujeo, it led to a significant reduction in risk of hypoglycemia without compromising blood sugar control"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017",2017-04-04 13:11:00 +0000,http://finance.yahoo.com/news/grifols-2016-annual-report-form-131100991.html?.tsrc=rss,"BARCELONA, Spain, April 4, 2017 /PRNewswire/ -- Grifols, S.A. (""Grifols"") (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) announced that it has filed its 2016 Annual Report on Form 20-F with the United ..."
GRFS,GRFS:UW,BBG001QMCL19,New Breakout Stocks Zacks Rank #1 (Strong Buy),2017-04-01 17:58:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/twZyl8uW29g/new-breakout-stocks-zacks-rank-1-strong-buy-cm768727,Another day another dive into the charts Check out the video above for Dave s Daily Dive into the Charts Today s dive includes a brief look at the NASDAQ and its epic run Then we look at the S amp P 500 and it s possible rolling over to the downside The small caps of the Russell are
GRFS,GRFS:UW,BBG001QMCL19,New Breakout Stocks Zacks Rank #1 (Strong Buy),2017-04-01 16:12:04 +0000,http://finance.yahoo.com/news/breakout-stocks-zacks-rank-1-161204750.html,New Breakout Stocks Zacks Rank #1 (Strong Buy)
GRFS,GRFS:UW,BBG001QMCL19,New Breakout Stocks Zacks Rank #1 (Strong Buy),2017-04-01 16:12:04 +0000,http://finance.yahoo.com/news/breakout-stocks-zacks-rank-1-161204750.html?.tsrc=rss,"Today???s dive includes a brief look at the NASDAQ and its epic run. Then we look at the S&P 500, and it???s possible rolling over to the downside. The small caps of the Russell are range bound, but where is the top end? All that and more in today???s episode."
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Edge Lower as Pharmaceutical Stocks See Mixed Fortunes,2017-03-31 15:19:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eDQgi015Yjs/european-adrs-edge-lower-as-pharmaceutical-stocks-see-mixed-fortunes-cm768299,American depository receipts of European stocks were 0 3 lower at 126 90 on the Bank of New York Mellon Europe ADR Index on Friday morning American depository receipts of European stocks were 0 3 lower at 126 90 on the Bank of New York Mellon Europe ADR Index on Friday morning Decliners
GRFS,GRFS:UW,BBG001QMCL19,AbbVie's (ABBV) Humira Drug Label Update Approved by FDA,2017-03-31 15:03:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ijmGdjs2Nd0/abbvies-abbv-humira-drug-label-update-approved-by-fda-cm768272,AbbVie Inc s ABBV announced that the FDA has approved the inclusion of moderate to severe fingernail psoriasis data on the label of AbbVie s multi utility TNF blocker drug Humira With this approval Humira becomes the first and the only drug to include data on fingernail psoriasis in
GRFS,GRFS:UW,BBG001QMCL19,AbbVie's (ABBV) Humira Drug Label Update Approved by FDA,2017-03-31 12:41:12 +0000,http://finance.yahoo.com/news/abbvies-abbv-humira-drug-label-124112552.html?.tsrc=rss,"AbbVie Inc.'s (ABBV) announced that the FDA has approved the inclusion of moderate to severe fingernail psoriasis data on the label of AbbVie???s multi-utility TNF blocker drug, Humira"
GRFS,GRFS:UW,BBG001QMCL19,AbbVie's (ABBV) Humira Drug Label Update Approved by FDA,2017-03-31 12:41:12 +0000,http://finance.yahoo.com/news/abbvies-abbv-humira-drug-label-124112552.html,AbbVie's (ABBV) Humira Drug Label Update Approved by FDA
GRFS,GRFS:UW,BBG001QMCL19,New Strong Buy Stocks for March 30th,2017-03-30 18:01:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QSz_xk1xeXY/new-strong-buy-stocks-for-march-30th-cm767929,Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today Dycom Industries Inc DY This provider of specialty contracting services has witnessed the Zacks Consensus Estimate for its current year earnings surging 6 1 over the last 30 days Dycom Industries Inc
GRFS,GRFS:UW,BBG001QMCL19,New Strong Buy Stocks for March 30th,2017-03-30 14:51:02 +0000,http://finance.yahoo.com/news/strong-buy-stocks-march-30th-145102543.html?.tsrc=rss,New Strong Buy Stocks for March 30th
GRFS,GRFS:UW,BBG001QMCL19,New Strong Buy Stocks for March 30th,2017-03-30 14:51:02 +0000,http://finance.yahoo.com/news/strong-buy-stocks-march-30th-145102543.html,New Strong Buy Stocks for March 30th
GRFS,GRFS:UW,BBG001QMCL19,Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%,2017-03-28 14:03:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vJxJYm_Qmao/catalyst-pharmaceuticals-cprx-jumps-stock-gains-182-cm766604,Catalyst Pharmaceuticals Inc CPRX was a big mover last session as its shares rose over 18 on the day The move came on solid volume too with far more shares changing hands than in a normal session 160 This continues the recent uptrend for the company as the stock is now up almost 78
GRFS,GRFS:UW,BBG001QMCL19,Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%,2017-03-28 12:15:12 +0000,http://finance.yahoo.com/news/catalyst-pharmaceuticals-cprx-jumps-stock-121512764.html?.tsrc=rss,"Catalyst Pharmaceuticals, Inc. (CPRX) moved big last session, as its shares rose over 18% on the day."
GRFS,GRFS:UW,BBG001QMCL19,Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%,2017-03-28 12:15:12 +0000,http://finance.yahoo.com/news/catalyst-pharmaceuticals-cprx-jumps-stock-121512764.html,Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%
GRFS,GRFS:UW,BBG001QMCL19,5 Cheap PEG Picks for Value Investors Right Now,2017-03-22 14:10:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q7E03b_z4Mg/5-cheap-peg-picks-for-value-investors-right-now-cm763988,Investment is becoming a challenging task with each passing day thanks to the global stock market s persistent inconstancy on political or economic factors While President Donald Trump s first budget blue print has started to create quite a stir within the investment world it is always wise
GRFS,GRFS:UW,BBG001QMCL19,5 Cheap PEG Picks for Value Investors Right Now,2017-03-22 12:19:12 +0000,http://finance.yahoo.com/news/5-cheap-peg-picks-value-121912214.html,5 Cheap PEG Picks for Value Investors Right Now
GRFS,GRFS:UW,BBG001QMCL19,Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod,2017-03-21 21:08:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s3huNu9biqI/allergans-dermal-filler-for-wrinkle-correction-gets-fda-nod-cm763764,Allergan plc AGN announced yesterday that the FDA has approved its Juvederm Vollure XC dermal filler for correction of facial wrinkles and folds in adults over the age of 21 The approval was based on the data from a U S pivotal clinical trial It showed that 59 of patients under test
GRFS,GRFS:UW,BBG001QMCL19,Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod,2017-03-21 18:58:06 +0000,http://finance.yahoo.com/news/allergans-dermal-filler-wrinkle-correction-185806943.html?.tsrc=rss,Allergan plc (AGN) announced yesterday that the FDA has approved its Juvederm Vollure XC dermal filler for correction of facial wrinkles and folds in adults over the age of 21.
GRFS,GRFS:UW,BBG001QMCL19,Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod,2017-03-21 18:58:06 +0000,http://finance.yahoo.com/news/allergans-dermal-filler-wrinkle-correction-185806943.html,Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
GRFS,GRFS:UW,BBG001QMCL19,AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal,2017-03-20 17:08:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VD0jEST0MYE/astrazeneca-azn-gets-another-crl-for-zs-9-inks-copd-deal-cm763005,London based AstraZeneca plc AZN received a second Complete Response Letter CRL from the FDA for its new drug application NDA for investigational drug ZS 9 The company is looking to get ZS 9 sodium zirconium cyclosilicate approved for the treatment of hyperkalemia high potassium level
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Fractionally Higher as Health Care Stocks See Mixed Fortunes,2017-03-20 15:06:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rk_Ax4qp1LU/european-adrs-fractionally-higher-as-health-care-stocks-see-mixed-fortunes-cm762874,American depository receipts of European stocks were 0 1 higher at 127 36 on the Bank of New York Mellon Europe ADR Index on Monday morning American depository receipts of European stocks were 0 1 higher at 127 36 on the Bank of New York Mellon Europe ADR Index on Monday morning Gainers
GRFS,GRFS:UW,BBG001QMCL19,AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal,2017-03-20 14:32:02 +0000,http://finance.yahoo.com/news/astrazeneca-azn-gets-another-crl-143202137.html?.tsrc=rss,London based AstraZeneca plc (AZN) received a second Complete Response Letter (CRL) from the FDA for its new drug application (NDA) for investigational drug ZS-9.
GRFS,GRFS:UW,BBG001QMCL19,AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal,2017-03-20 14:32:02 +0000,http://finance.yahoo.com/news/astrazeneca-azn-gets-another-crl-143202137.html,AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
GRFS,GRFS:UW,BBG001QMCL19,Is Grifols a Great Stock for Value Investors?,2017-03-17 16:09:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CqARFz7NGqc/is-grifols-a-great-stock-for-value-investors-cm762278,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
GRFS,GRFS:UW,BBG001QMCL19,Is Grifols a Great Stock for Value Investors?,2017-03-17 13:50:01 +0000,http://finance.yahoo.com/news/grifols-great-stock-value-investors-135001644.html,Is Grifols a Great Stock for Value Investors?
GRFS,GRFS:UW,BBG001QMCL19,Is Grifols a Great Stock for Value Investors?,2017-03-17 13:50:01 +0000,http://finance.yahoo.com/news/grifols-great-stock-value-investors-135001644.html?.tsrc=rss,"Let's focus on Grifols, S.A. (GRFS) stock and find out if it is a good choice for value-oriented investors right now or not."
GRFS,GRFS:UW,BBG001QMCL19,Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session,2017-03-10 15:16:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MXiqBN2CFs0/aurinia-auph-catches-eye-stock-moves-up-85-in-session-cm759207,Aurinia Pharmaceuticals Inc AUPH was a big mover last session as its shares rose above 8 on the day The move came after the company reported fourth quarter and full year 2016 earnings This also led to far more shares changing hands than in a normal session This continues the recent
GRFS,GRFS:UW,BBG001QMCL19,Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session,2017-03-10 13:15:01 +0000,http://finance.yahoo.com/news/aurinia-auph-catches-eye-stock-131501134.html,Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session
GRFS,GRFS:UW,BBG001QMCL19,New Strong Buy Stocks for March 9th,2017-03-09 17:17:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lECyi-cPq98/new-strong-buy-stocks-for-march-9th-cm758680,Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today Advanced Accelerator Application SA AAAP This radiopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0 9 over the last 30 days Advanced
GRFS,GRFS:UW,BBG001QMCL19,Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%,2017-03-09 15:17:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SKcjATkAOkA/esperion-therapeutics-espr-jumps-stock-moves-up-86-cm758416,Esperion Therapeutics Inc ESPR was a big mover last session as its shares rose above 8 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up almost 68 in the
GRFS,GRFS:UW,BBG001QMCL19,New Strong Buy Stocks for March 9th,2017-03-09 14:27:02 +0000,http://finance.yahoo.com/news/strong-buy-stocks-march-9th-142702191.html,New Strong Buy Stocks for March 9th
GRFS,GRFS:UW,BBG001QMCL19,Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%,2017-03-09 13:15:01 +0000,http://finance.yahoo.com/news/esperion-therapeutics-espr-jumps-stock-131501093.html,Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%
GRFS,GRFS:UW,BBG001QMCL19,Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%,2017-03-09 13:15:01 +0000,http://finance.yahoo.com/news/esperion-therapeutics-espr-jumps-stock-131501093.html?.tsrc=rss,"Esperion Therapeutics, Inc. (ESPR) moved big last session, as its shares rose above 8% on the day."
GRFS,GRFS:UW,BBG001QMCL19,5 European Stocks to Buy as Trump Rally Weakens,2017-03-07 22:48:10 +0000,http://finance.yahoo.com/news/5-european-stocks-buy-trump-224810041.html,5 European Stocks to Buy as Trump Rally Weakens
GRFS,GRFS:UW,BBG001QMCL19,5 European Stocks to Buy as Trump Rally Weakens,2017-03-07 22:48:10 +0000,http://finance.yahoo.com/news/5-european-stocks-buy-trump-224810041.html?.tsrc=rss,"There is a compelling case for looking beyond the success of U.S. stocks and diversifying into other markets, particularly Europe"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA :GRFS-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017",2017-03-06 17:24:53 +0000,http://finance.yahoo.com/r/9ca64578-81aa-34b5-b249-bbe3fcd47da0/grifols-sa-grfs-us-earnings-analysis-2016-by-the-numbers-march-6-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Grifols SA reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Grifols SA – Baxter International Inc., China Biologic Products, Inc., Amgen Inc., China Cord Blood Corporation, Kimberly-Clark Corporation, Johnson & Johnson and Mylan N.V. (BAX-US, CBPO-US, AMGN-US, CO-US, KMB-US, ... Read more    
<b>(Read more...)</b>"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA :GRFS-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017",2017-03-06 17:24:53 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-earnings-analysis-2016-by-the-numbers-march-6-2017/,"Grifols SA :GRFS-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA :GRFS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017",2017-03-03 15:46:39 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-earnings-analysis-q4-2016-by-the-numbers-march-3-2017/,"Grifols SA :GRFS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017"
GRFS,GRFS:UW,BBG001QMCL19,Blog Coverage Kite Pharma CAR-T Cancer Therapy Demonstrate Positive Results in B-cell non-Hodgkin Lymphoma,2017-03-02 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-kite-pharma-car-131500556.html,"[Accesswire] - Upcoming AWS Coverage on Grifols LONDON, UK / ACCESSWIRE / March 2, 2017 / Active Wall St. blog coverage looks at the headline from Kite Pharma Inc. (NASDAQ: KITE ) as the Company announced on February ..."
GRFS,GRFS:UW,BBG001QMCL19,Blog Coverage Kite Pharma CAR-T Cancer Therapy Demonstrate Positive Results in B-cell non-Hodgkin Lymphoma,2017-03-02 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-kite-pharma-car-131500556.html?.tsrc=rss,"Upcoming AWS Coverage on Grifols LONDON, UK / ACCESSWIRE / March 2, 2017 / Active Wall St. blog coverage looks at the headline from Kite Pharma Inc. (NASDAQ: KITE ) as the Company announced on February ..."
GRFS,GRFS:UW,BBG001QMCL19,Infinity Pharmaceuticals (INFI) Catches Eye: Stock Up 13.5%,2017-03-01 15:15:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CyeiTy1qv4Q/infinity-pharmaceuticals-infi-catches-eye-stock-up-135-cm754833,Infinity Pharmaceuticals Inc INFI was a big mover last session as the company saw its shares rise almost 7 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above
GRFS,GRFS:UW,BBG001QMCL19,"Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million",2017-01-31 21:05:00 +0000,http://finance.yahoo.com/news/grifols-closes-acquisition-hologics-share-210500371.html,"[PR Newswire] - BARCELONA, Spain, Jan. 31, 2017 /PRNewswire/ -- The company consolidates a leading position of its Diagnostic Division enhancing its integration Grifols completes in record time the acquisition of the ..."
GRFS,GRFS:UW,BBG001QMCL19,"Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million",2017-01-31 21:05:00 +0000,http://finance.yahoo.com/news/grifols-closes-acquisition-hologics-share-210500371.html?.tsrc=rss,"BARCELONA, Spain, Jan. 31, 2017 /PRNewswire/ --  The company consolidates a leading position of its Diagnostic Division enhancing its integration Grifols completes in record time the acquisition of the ..."
GRFS,GRFS:UW,BBG001QMCL19,Hologic Completes Divestiture of Blood Screening Business,2017-01-31 21:01:00 +0000,http://finance.yahoo.com/news/hologic-completes-divestiture-blood-screening-210100702.html?.tsrc=rss,"MARLBOROUGH, Mass., Jan. 31, 2017 /PRNewswire/ -- Hologic, Inc. (HOLX) has completed the divestiture of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) for a purchase price of $1.85 billion in cash, the Company announced today.  Hologic intends to discuss the financial effects of the transaction tomorrow, when it releases its quarterly financial results and provides updated financial guidance."
GRFS,GRFS:UW,BBG001QMCL19,Hologic Completes Divestiture of Blood Screening Business,2017-01-31 21:01:00 +0000,http://finance.yahoo.com/news/hologic-completes-divestiture-blood-screening-210100702.html,"[PR Newswire] - MARLBOROUGH, Mass., Jan. 31, 2017 /PRNewswire/ -- Hologic, Inc. (HOLX) has completed the divestiture of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) for a purchase price of $1.85 billion in cash, the Company announced today. Hologic intends to discuss the financial effects of the transaction tomorrow, when it releases its quarterly financial results and provides updated financial guidance."
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017",2017-01-30 17:26:32 +0000,http://finance.yahoo.com/r/39d0b610-5808-3930-8346-064244d93d61/grifols-sa-grfs-us-dividend-analysis-december-07th-2016-record-date-by-the-numbers-january-30-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Our analysis is based on comparing Grifols SA with the following peers – Baxter International Inc., China Biologic Products, Inc., Amgen Inc., China Cord Blood Corporation, Kimberly-Clark Corporation, Johnson & Johnson, Cord Blood America, Inc., Aradigm Corporation and Mylan N.V. (BAX-US, CBPO-US, AMGN-US, CO-US, KMB-US, JNJ-US, CBAI-US, ARDM-US and MYL-US). Grifols ... Read more    
<b>(Read more...)</b>"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017",2017-01-30 17:26:32 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-dividend-analysis-december-07th-2016-record-date-by-the-numbers-january-30-2017/,"Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols, S.A. upgraded by JP Morgan",2017-01-03 16:51:33 +0000,http://finance.yahoo.com/q/ud?s=GRFS,"Grifols, S.A. upgraded by JP Morgan"
GRFS,GRFS:UW,BBG001QMCL19,Interesting GRFS Put And Call Options For August 2017,2016-12-20 16:59:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OFXh7VENNeo/interesting-grfs-put-and-call-options-for-august-2017-cm723984,Investors in Grifols SA Barcelona Symbol GRFS saw new options begin trading this week for the August 2017 expiration One of the key data points that goes into the price an option buyer is willing to pay is the time value so with 241 days until expiration the newly trading
GRFS,GRFS:UW,BBG001QMCL19,Hologic (HOLX) to Divest Blood Screening Business to Grifols,2016-12-19 13:57:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z-PcK8hbfYc/hologic-holx-to-divest-blood-screening-business-to-grifols-cm723127,To focus more on its core business Hologic Inc HOLX recently inked a deal to divest its stake in the blood screening business Per the terms of the agreement the company will sell off its share to its long time commercial partner in blood screening business Grifols GRFS for gross
GRFS,GRFS:UW,BBG001QMCL19,Hologic (HOLX) to Divest Blood Screening Business to Grifols,2016-12-19 12:46:12 +0000,http://finance.yahoo.com/news/hologic-holx-divest-blood-screening-124612429.html,Hologic (HOLX) to Divest Blood Screening Business to Grifols
GRFS,GRFS:UW,BBG001QMCL19,Hologic (HOLX) to Divest Blood Screening Business to Grifols,2016-12-19 12:46:12 +0000,http://finance.yahoo.com/news/hologic-holx-divest-blood-screening-124612429.html?.tsrc=rss,"Hologic, Inc. (HOLX) recently inked a deal to divest its stake in the blood screening business."
GRFS,GRFS:UW,BBG001QMCL19,Hologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit,2016-12-15 21:42:12 +0000,http://www.investors.com/news/technology/hologic-in-buy-zone-after-divesting-slowing-blood-screening-unit/,Hologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit
GRFS,GRFS:UW,BBG001QMCL19,Hologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit,2016-12-15 21:42:12 +0000,http://finance.yahoo.com/r/e6af7d6c-d59b-3eb0-a475-9f499366a9e3/hologic-in-buy-zone-after-divesting-slowing-blood-screening-unit?yptr=yahoo&.tsrc=rss,Hologic sold its declining blood screening venture to partner Grifols. The $1.8 billion price was &quot;lofty&quot; according to a Canaccord analyst.
GRFS,GRFS:UW,BBG001QMCL19,Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B,2016-12-15 00:14:00 +0000,https://www.thestreet.com/story/13926549/1/hologic-agrees-to-sell-blood-screening-business-to-grifols-for-1-85b.html?puc=yahoo&cm_ven=YAHOO,Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B
GRFS,GRFS:UW,BBG001QMCL19,Hologic To Sell Blood Screening Business To Grifols For $1.85 Bln,2016-12-14 23:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UjWquzWAoS8/hologic-to-sell-blood-screening-business-to-grifols-for-185-bln-20161214-01129,Hologic To Sell Blood Screening Business To Grifols For $1.85 Bln
GRFS,GRFS:UW,BBG001QMCL19,Grifols to buy Hologic's stake in blood screening JV for $1.85 billion,2016-12-14 22:33:36 +0000,http://sg.finance.yahoo.com/news/grifols-buy-hologics-stake-blood-215226582.html,Grifols to buy Hologic's stake in blood screening JV for $1.85 billion
GRFS,GRFS:UW,BBG001QMCL19,Hologic to sell stake in blood screening unit for $1.85 bln,2016-12-14 21:43:10 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=A9397F60-5C6A-4466-B0CC-3C5E72545A60&siteid=yhoof2,Hologic to sell stake in blood screening unit for $1.85 bln
GRFS,GRFS:UW,BBG001QMCL19,"4:30 pm Grifols, S.A. confirms acquisition of Hologic's (<a href=""/q?s=holx"" name=""holx"">HOLX</a>) interest in their existing joint-business",2016-12-14 21:30:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#grfs,"4:30 pm Grifols, S.A. confirms acquisition of Hologic's (<a href=""/q?s=holx"" name=""holx"">HOLX</a>) interest in their existing joint-business"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million",2016-12-14 21:15:00 +0000,http://finance.yahoo.com/news/grifols-agrees-acquire-hologics-share-211500589.html,"[PR Newswire] - BARCELONA, Spain, Dec. 14, 2016 /PRNewswire/ -- Grifols entered into an agreement to acquire Hologic's (Nasdaq: HOLX) interest in their existing joint-business under which Grifols owns all customer facing ..."
GRFS,GRFS:UW,BBG001QMCL19,Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion,2016-12-14 21:01:00 +0000,http://finance.yahoo.com/news/hologic-divest-blood-screening-business-210100450.html,"[PR Newswire] - MARLBOROUGH, Mass., Dec. 14, 2016 /PRNewswire/ -- Hologic, Inc. (HOLX) has entered into a definitive agreement to sell its share of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), for gross proceeds of $1.85 billion in cash, the Company announced today. The transaction has been approved by the boards of directors of both companies."
GRFS,GRFS:UW,BBG001QMCL19,Grifols To Buy Hologic's NAT Donor Screening Unit For $1.85 Bln,2016-12-14 17:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kb8KmTR2IwQ/grifols-to-buy-hologics-nat-donor-screening-unit-for-185-bln-20161214-01005,Grifols To Buy Hologic's NAT Donor Screening Unit For $1.85 Bln
GRFS,GRFS:UW,BBG001QMCL19,"ETFs with exposure to Grifols SA : December 13, 2016",2016-12-13 17:56:10 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-grifols-sa-december-13-2016/,"ETFs with exposure to Grifols SA : December 13, 2016"
GRFS,GRFS:UW,BBG001QMCL19,Virgin America Inc (VA): Is It Right For Your Portfolio?,2016-12-09 23:52:52 +0000,http://www.insidermonkey.com/blog/virgin-america-inc-va-is-it-right-for-your-portfolio-493058/,Virgin America Inc (VA): Is It Right For Your Portfolio?
GRFS,GRFS:UW,BBG001QMCL19,Ligand Pharmaceuticals Inc. (LGND): Hedge Fund Sentiment Unchanged,2016-12-05 11:45:53 +0000,http://www.insidermonkey.com/blog/ligand-pharmaceuticals-inc-lgnd-hedge-fund-sentiment-unchanged-497782/,Ligand Pharmaceuticals Inc. (LGND): Hedge Fund Sentiment Unchanged
GRFS,GRFS:UW,BBG001QMCL19,"ETFs with exposure to Grifols SA : December 2, 2016",2016-12-02 17:29:23 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-grifols-sa-december-2-2016/,"ETFs with exposure to Grifols SA : December 2, 2016"
GRFS,GRFS:UW,BBG001QMCL19,John Paulson's Largest 3rd Quarter Trades,2016-12-01 21:29:33 +0000,http://finance.yahoo.com/news/john-paulsons-largest-3rd-quarter-212933592.html,John Paulson's Largest 3rd Quarter Trades
GRFS,GRFS:UW,BBG001QMCL19,What Explains the Huge Jump in Louisiana-Pacific Corporation (LPX)’s Hedge Fund Ownership?,2016-11-26 03:10:50 +0000,http://www.insidermonkey.com/blog/what-explains-the-huge-jump-in-louisiana-pacific-corporation-lpxs-hedge-fund-ownership-491973/,What Explains the Huge Jump in Louisiana-Pacific Corporation (LPX)’s Hedge Fund Ownership?
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA :GRFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016",2016-11-11 15:11:49 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-earnings-analysis-q3-2016-by-the-numbers-november-11-2016/,"Grifols SA :GRFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016"
GRFS,GRFS:UW,BBG001QMCL19,Bullish Two Hundred Day Moving Average Cross - GRFS,2016-11-09 19:52:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7kFDzrxPNGg/bullish-two-hundred-day-moving-average-cross-grfs-cm706652,In trading on Wednesday shares of Grifols SA Barcelona Symbol GRFS crossed above their 200 day moving average of 15 74 changing hands as high as 16 04 per share Grifols SA Barcelona shares are currently trading up about 4 on the day The chart below shows the one year performance of
GRFS,GRFS:UW,BBG001QMCL19,"Sales of the Bioscience Division grow by +6.5%, increasing Grifols’ revenues to EUR 2,952 million Download (377.6 Kb)",2016-11-08 11:25:13 +0000,http://www.publicnow.com/view/F08AC07E9FD070EA497BA86E555DD1C28876B2D4,"[at noodls] - Results for the nine months ended September 2016 Sales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million Revenues over EUR 1,000 million and growth in the three ..."
GRFS,GRFS:UW,BBG001QMCL19,"Sales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million",2016-11-08 11:25:08 +0000,http://www.publicnow.com/view/0FD3E94769FB89C43F165C1861C5A2BEABECAC4E,"[at noodls] - Revenues over EUR 1,000 million and growth in the three divisions during the third quarter Revenues of the Bioscience Division for the nine months ended September 2016 total EUR 2,356.4 million, rising ..."
GRFS,GRFS:UW,BBG001QMCL19,First Week of GRFS December 16th Options Trading,2016-10-27 15:43:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AAtlyd2CMic/first-week-of-grfs-december-16th-options-trading-cm699340,Investors in Grifols SA Barcelona Symbol GRFS saw new options become available this week for the December 16th expiration At Stock Options Channel our YieldBoost formula has looked up and down the GRFS options chain for the new December 16th contracts and identified the following
GRFS,GRFS:UW,BBG001QMCL19,The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests,2016-10-20 23:37:00 +0000,http://uk.finance.yahoo.com/news/clia-lab-grifols-immunohematology-center-233700814.html,The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests
GRFS,GRFS:UW,BBG001QMCL19,Grifols relocates its headquarters in Germany to a new office building,2016-10-13 09:20:00 +0000,http://www.publicnow.com/view/DAE909D66A2F8F0DA1C5936D85721AAF52B59F2B,"[at noodls] - Grifols has a commercial subsidiary in Germany since 1997 and following the acquisition of Talecris in 2011, the country also hosts the commercial headquarters of the Bioscience Division in Europe The ..."
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : October 7, 2016",2016-10-07 15:14:09 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-dividend-analysis-june-06th-2016-record-date-by-the-numbers-october-7-2016/,"Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : October 7, 2016"
GRFS,GRFS:UW,BBG001QMCL19,5 Big Dividend Stocks Billionaire John Paulson Loves,2016-09-08 11:39:00 +0000,https://www.thestreet.com/story/13110189/1/john-paulsons-top-dividend-stocks.html?puc=yahoo&cm_ven=YAHOO,5 Big Dividend Stocks Billionaire John Paulson Loves
GRFS,GRFS:UW,BBG001QMCL19,Why Is JOHIX Doing So Well Year-to-Date?,2016-09-07 23:04:17 +0000,http://marketrealist.com/2016/09/why-is-johix-doing-so-well-year-to-date/?utm_source=yahoo&utm_medium=feed,Why Is JOHIX Doing So Well Year-to-Date?
GRFS,GRFS:UW,BBG001QMCL19,Grifols Opens Diagnostic Training Center in Dubai,2016-09-05 09:32:00 +0000,http://finance.yahoo.com/news/grifols-opens-diagnostic-training-center-093200248.html,"[PR Newswire] - BARCELONA, Spain, Sept. 5, 2016 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company with more than 75-year legacy of improving people's health and well-being, today celebrated the opening of its new training center in Dubai. Created to support the company's growing Diagnostic business, the center will offer single and multi-day training courses for laboratory technicians, engineers, and specialists working with the company's broad portfolio of Transfusion Medicine and Clinical Diagnostic instruments, assays, and software. ""Locating this new center in Dubai, a city focused on being a healthcare center of excellence, allows us to more closely partner with customers throughout the Middle East and Africa working to provide excellent care to patients,"" said Carsten Schroeder, president of the Grifols Diagnostic Division."
GRFS,GRFS:UW,BBG001QMCL19,Grifols Opens Diagnostic Training Center in Dubai,2016-09-05 08:48:03 +0000,http://www.publicnow.com/view/3F59DF77CE8E1503D960E035A26DB1B808881DE1,"[at noodls] - The new center, part of Grifols growing Diagnostic business, will train laboratory technicians, engineers, and specialists on Grifols systems and laboratory best practices. Grifols expanded presence in ..."
GRFS,GRFS:UW,BBG001QMCL19,New Zika Screening Rule Could Boost Hologic Sales Growth,2016-08-26 20:38:24 +0000,http://www.investors.com/news/technology/new-zika-screening-rule-could-boost-hologic-sales-growth/,New Zika Screening Rule Could Boost Hologic Sales Growth
GRFS,GRFS:UW,BBG001QMCL19,"ETF’s with exposure to Grifols SA : August 25, 2016",2016-08-25 14:16:03 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-grifols-sa-august-25-2016/,"ETF’s with exposure to Grifols SA : August 25, 2016"
GRFS,GRFS:UW,BBG001QMCL19,Grif_ls support the Canadian Blood Services' Missing Type Campaign,2016-08-16 12:01:03 +0000,http://www.publicnow.com/view/17A0805419449D704A62E2A9B90290E0A17A9733,[at noodls] - Grifols is proud to support the Canadian Blood Services' Missing Type Campaign. This is a global campaign whose goal is to increase the number of new registered blood donors. In the last decade there has ...
GRFS,GRFS:UW,BBG001QMCL19,The results of phase I clinical trial of the Araclon Biotech Alzheimer's vaccine support its continuation,2016-08-01 10:21:08 +0000,http://www.publicnow.com/view/46D980F92FF26D491672F6F79062186B9509712E,"[at noodls] - The conclusions of the trial were presented at the Alzheimer's Association International Conference in Toronto. The compound ABvac40, designed to combat Alzheimer's disease at its initial stage, has demonstrated ..."
GRFS,GRFS:UW,BBG001QMCL19,"Sales of the Bioscience Division grow by +7.0%, increasing Grifols' revenues by +2.7% to EUR 1,952 million",2016-07-28 10:08:10 +0000,http://www.publicnow.com/view/0E556B6AF068CEC51A06C775924295B282130925,"[at noodls] - Strong positive growth for the four main plasma proteins, that jointly with the others, take the revenues of the Bioscience Division to EUR 1,559.3 million with an increase of +7.0% (+6.7% cc) Significant ..."
GRFS,GRFS:UW,BBG001QMCL19,"Sales of the Bioscience Division grow by +7.0%, increasing Grifols’ revenues by +2.7% to EUR 1,952 million Download (437.5 Kb)",2016-07-28 07:38:13 +0000,http://www.publicnow.com/view/04A713D50E9D79B30A95320848CE84146FA34FDA,"[at noodls] - Results for the first half of 2016 Sales of the Bioscience Division grow by +7.0%, increasing Grifols' revenues by +2.7% to EUR 1,952 million Strong positive growth for the four main plasma proteins, that ..."
GRFS,GRFS:UW,BBG001QMCL19,Award Winners of the 9th Annual Martín Villar Haemostasis Awards,2016-07-27 09:58:01 +0000,http://www.publicnow.com/view/24EBC3E8879EF55A5023E8711ADD23DA053C8EC5,"[at noodls] - Created in 2007, the awards recognize the progress made in the field of Hemostasis. The awards are endowed with 20,000 euros for each of the two prizes: Basic Research and Clinical Research. The Basic ..."
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : July 26, 2016",2016-07-26 15:01:58 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-earnings-analysis-q1-2016-by-the-numbers-july-26-2016/,"Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : July 26, 2016"
GRFS,GRFS:UW,BBG001QMCL19,"ETF’s with exposure to Grifols SA : July 25, 2016",2016-07-25 17:29:07 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-grifols-sa-july-25-2016/,"ETF’s with exposure to Grifols SA : July 25, 2016"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12, 2016",2016-07-12 16:20:50 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-dividend-analysis-june-06th-2016-record-date-by-the-numbers-july-12-2016/,"Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12, 2016"
GRFS,GRFS:UW,BBG001QMCL19,Pedigri®: the tool that increases the information transparency to the plasma-derived manufactured in Clayton,2016-07-05 14:01:06 +0000,http://www.publicnow.com/view/45BD94BD2BF087B90353D8D88C38E6F995FD4668,"[at noodls] - GammaSTAN, Gamunex / Gamunex-C, HyperHEP B, HyperRAB, HyperRHO, HyperTET, Koāte DVI, Plasbumin, Prolastin / Prolastin C and Thrombate III are the newly added products. Grifols has been offering this unique ..."
GRFS,GRFS:UW,BBG001QMCL19,"ETF’s with exposure to Grifols SA : June 30, 2016",2016-06-30 16:08:14 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-grifols-sa-june-30-2016/,"ETF’s with exposure to Grifols SA : June 30, 2016"
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Marginally Higher as Healthcare Stocks See Mixed Fortunes,2016-06-30 16:02:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sf4e07c76hU/european-adrs-marginally-higher-as-healthcare-stocks-see-mixed-fortunes-cm643328,"American depository receipts of European stocks were trading 0.2% higher at 118.64 on the Bank of New York Mellon Europe ADR Index on Thursday morning. Gainers in Continental Europe were led by Sequans Communications ( SQNS ), a French"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : June 29, 2016",2016-06-29 18:42:26 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-dividend-analysis-june-06th-2016-record-date-by-the-numbers-june-29-2016/,"Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : June 29, 2016"
GRFS,GRFS:UW,BBG001QMCL19,Award Winner of the 2016 SPIN Awards Program,2016-06-29 06:31:05 +0000,http://www.publicnow.com/view/DEAED8B99F3C2FB06984645ADED49BEA3E1670A1,"[at noodls] - Created in 2008, the SPIN Awards Program supports the development and testing of innovative ideas and hypotheses in the field of immunoglobulin research in neurology. The research project was awarded to ..."
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 : By the numbers : June 23, 2016",2016-06-23 03:33:47 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-dividend-analysis-june-06th-2016-by-the-numbers-june-23-2016/,"Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 : By the numbers : June 23, 2016"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016",2016-06-22 16:54:34 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-earnings-analysis-q1-2016-by-the-numbers-june-22-2016/,"Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016"
GRFS,GRFS:UW,BBG001QMCL19,FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol,2016-06-21 10:29:02 +0000,http://www.publicnow.com/view/C105392B4F307B23757852B98B96DE6613E483ED,"[at noodls] - Blood banks will use the new test, co-developed by Hologic and Grifols, to screen donated blood in potential endemic areas of the US. Test will run on the Procleix Panther System, a fully automated NAT ..."
GRFS,GRFS:UW,BBG001QMCL19,"Zika Blood Screening Test From Hologic, Grifols Gets FDA Nod",2016-06-20 20:31:55 +0000,http://www.investors.com/news/technology/zika-blood-screening-test-from-hologic-grifols-gets-fda-nod/?ven=YahooCP&src=AURLLED&ven=yahoo,"Zika Blood Screening Test From Hologic, Grifols Gets FDA Nod"
GRFS,GRFS:UW,BBG001QMCL19,Hologic And Grifols Get FDA Approval For Procleix Zika Virus Assay,2016-06-20 14:59:27 +0000,http://finance.yahoo.com/news/hologic-grifols-fda-approval-procleix-145927056.html,Hologic And Grifols Get FDA Approval For Procleix Zika Virus Assay
GRFS,GRFS:UW,BBG001QMCL19,"FDA Okays Procleix Zika Virus Assay From Hologic, Grifols To Screen Blood Supply",2016-06-20 08:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vKlas9miqwc/fda-okays-procleix-zika-virus-assay-from-hologic-grifols-to-screen-blood-supply-20160620-00312,"FDA Okays Procleix Zika Virus Assay From Hologic, Grifols To Screen Blood Supply"
GRFS,GRFS:UW,BBG001QMCL19,Analyzing IBB’s Moving Averages,2016-06-16 13:05:30 +0000,http://marketrealist.com/2016/06/analyzing-ibbs-moving-averages/?utm_source=yahoo&utm_medium=feed&utm_content=main_permalink&utm_campaign=analyzing-ibbs-moving-averages,Analyzing IBB’s Moving Averages
GRFS,GRFS:UW,BBG001QMCL19,Grifols confirms that it has voluntarily signed the EFPIA Code of Conduct,2016-06-16 05:49:10 +0000,http://www.publicnow.com/view/779E09D795B24EE94ECB48498235D0418D8A3703,"[at noodls] - Barcelona, June 15, 2016. Grifols released its Corporate Social Responsibility policy on May 26, 2016, via the Spanish stock exchange regulator, the CNMV, and announced its decision to voluntarily adopt ..."
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Edge Lower as Oil and Gas Production Stocks Slide,2016-06-02 15:08:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HR5i3HZs1SE/european-adrs-edge-lower-as-oil-and-gas-production-stocks-slide-cm629519,American depository receipts of European stocks were trading 0.4% lower at 122.02 on the Bank of New York Mellon Europe ADR Index on Thursday morning as commodity contractions offset gains among pharmaceutical companies. Decliners in Continental Europe were led
GRFS,GRFS:UW,BBG001QMCL19,Grifols Maintains Its Dividend Payout at 40%,2016-06-01 13:07:29 +0000,http://finance.yahoo.com/news/grifols-maintains-dividend-payout-40-130729483.html,Grifols Maintains Its Dividend Payout at 40%
GRFS,GRFS:UW,BBG001QMCL19,Singulex announces a $50 million investment by Grifols for a 20% stake in the company,2016-05-31 12:26:00 +0000,http://finance.yahoo.com/news/singulex-announces-50-million-investment-122600706.html,"[PR Newswire] - ALAMEDA, Calif. and BARCELONA, Spain, May 31, 2016 /PRNewswire/ -- Singulex, Inc., the leader in next generation immunodiagnostic technology powered by single molecule counting, announced today a partnership with Grifols, one of the world's largest plasma product manufacturers and a pioneer in the research and development of therapeutic alternatives designed to contribute to scientific development. Grifols has subscribed a share capital increase and holds a 20% stake in Singulex. The partnership provides Singulex US$50 million in exchange for Grifols' access to an exclusive worldwide license for the use and sale of Singulex' SMC technology for the screening of donor blood and plasma."
GRFS,GRFS:UW,BBG001QMCL19,Grifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net profit Download (222.1 Kb),2016-05-27 15:47:06 +0000,http://www.publicnow.com/view/9388544C72E1D5431DEDCC5F65BCA336FBF81F8D,[at noodls] - 02f682f4-41d9-4566-bda3-81b36d8ce219.pdf Grifols' Ordinary General Meeting of Shareholders Grifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net profit The company ...
GRFS,GRFS:UW,BBG001QMCL19,Grifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net profit,2016-05-27 14:17:08 +0000,http://www.publicnow.com/view/6288799E3C86B3557A81072BACC9F0848C670E0A,"[at noodls] - The company holds its Ordinary General Meeting of Shareholders at second call, with 81.96% of its share capital represented The shareholders endorse the management team and ratify all the items on the ..."
GRFS,GRFS:UW,BBG001QMCL19,"Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division",2016-05-05 13:41:02 +0000,http://www.publicnow.com/view/3594E5FB851DA84A14C45F54708FA423CAE0F430,[at noodls] - The Bioscience Division grows by +10.9% (+6.3% cc) and generates revenues of Euros 754.9 million. Positive growth of sales of the main plasma proteins Recurring revenues (excluding Raw Materials and Others) ...
GRFS,GRFS:UW,BBG001QMCL19,"Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division Download (256.2 Kb)",2016-05-05 07:01:02 +0000,http://www.publicnow.com/view/E7A50D213949ACD57B64039223C265A2A291A7C3,"[at noodls] - a932c575-1505-4f69-8430-2f6a724e7e29.pdf Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division The Bioscience Division grows by +10.9% (+6.3% ..."
GRFS,GRFS:UW,BBG001QMCL19,"ETF’s with exposure to Grifols SA : May 4, 2016",2016-05-04 20:10:45 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-grifols-sa-may-4-2016/,"ETF’s with exposure to Grifols SA : May 4, 2016"
GRFS,GRFS:UW,BBG001QMCL19,"After Hours Most Active for Apr 25, 2016 :  BAC, GE, GRFS, INTC, JCP, AAPL, GM, MSFT, KMI, DNR, EBAY, FB",2016-04-25 21:08:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3isfN4AS_IE/after-hours-most-active-for-apr-25-2016-bac-ge-grfs-intc-jcp-aapl-gm-msft-kmi-dnr-ebay-fb-cm611194,"The NASDAQ 100 After Hours Indicator is down 1.38 to 4,472.75. The total After hours volume is currently 27,273,112 shares traded. The following are the most active stocks for the after hours session Bank of America Corporation ( BAC"
GRFS,GRFS:UW,BBG001QMCL19,The Catalan Down's Syndrome Foundation and Grifols are working together to promote research,2016-04-18 15:43:16 +0000,http://www.publicnow.com/view/99B45601B07B86162DAC036CE4CD65AE032ECF20,"[at noodls] - Grifols has donated 150,000 euros to support the Foundation's research effort, designed to improve the quality of life of people with intellectual disability One of the lines of research, in partnership ..."
GRFS,GRFS:UW,BBG001QMCL19,GRIFOLS SA Financials,2016-04-08 17:04:22 +0000,http://finance.yahoo.com/q/is?s=grfs&annual,GRIFOLS SA Financials
GRFS,GRFS:UW,BBG001QMCL19,"ETF’s with exposure to Grifols SA : April 6, 2016",2016-04-06 21:20:38 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-grifols-sa-april-6-2016/,"ETF’s with exposure to Grifols SA : April 6, 2016"
GRFS,GRFS:UW,BBG001QMCL19,"Pre-Market Most Active for Apr 6, 2016 :  PDBC, PFE, TVIX, GRFS, QQQ, CREE, AAPL",2016-04-06 12:58:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yz9cfu1Ph4g/pre-market-most-active-for-apr-6-2016-pdbc-pfe-tvix-grfs-qqq-cree-aapl-cm602301,"The NASDAQ 100 Pre Market Indicator is up 13.44 to 4,484.19. The total Pre Market volume is currently 6,546,486 shares traded. The following are the most active stocks for the pre market session PowerShares DB Optimum Yield Diversified Commodity"
GRFS,GRFS:UW,BBG001QMCL19,Grifols could receive more than $12M from county if it meets hiring projections,2016-04-05 13:35:10 +0000,http://www.bizjournals.com/triangle/news/2016/04/05/grifols-could-receive-millions-johnston-county.html?ana=yahoo,Grifols could receive more than $12M from county if it meets hiring projections
GRFS,GRFS:UW,BBG001QMCL19,"Grifols 2015 Annual Report on Form 20-F filed with the SEC on April 5, 2016",2016-04-05 11:12:00 +0000,http://finance.yahoo.com/news/grifols-2015-annual-report-form-111200073.html,"[PR Newswire] - BARCELONA, Spain, April 5, 2016 /PRNewswire/ -- Grifols, S.A. (""Grifols"") (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS) announced that it has filed its 2015 Annual Report on Form 20-F with the United ..."
GRFS,GRFS:UW,BBG001QMCL19,"ETF’s with exposure to Grifols SA : March 10, 2016",2016-03-10 18:52:29 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-grifols-sa-march-10-2016/,"ETF’s with exposure to Grifols SA : March 10, 2016"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols SA :GRFS-US: Earnings Analysis: Q4, 2015 By the Numbers",2016-03-07 17:34:21 +0000,http://www.capitalcube.com/blog/index.php/grifols-sa-grfs-us-earnings-analysis-q4-2015-by-the-numbers/,"Grifols SA :GRFS-US: Earnings Analysis: Q4, 2015 By the Numbers"
GRFS,GRFS:UW,BBG001QMCL19,"Pre-Market Earnings Report for February 29, 2016 :  VRX, ENDP, IEP, NRG, HZNP, TRCO, VGR, ACAD, GRFS, BCPC, FI, SJI",2016-02-26 21:23:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jLwYswonWJI/pre-market-earnings-report-for-february-29-2016-vrx-endp-iep-nrg-hznp-trco-vgr-acad-grfs-bcpc-fi-sji-cm585626,"The following companies are expected to report earnings prior to market open on 02 29 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Valeant Pharmaceuticals International, Inc. ( VRX ) is"
GRFS,GRFS:UW,BBG001QMCL19,7 Big Dividend Stocks Billionaire John Paulson Loves,2016-02-21 13:33:00 +0000,http://www.thestreet.com/story/13110189/1/john-paulsons-top-dividend-stocks.html?puc=yahoo&cm_ven=YAHOO,7 Big Dividend Stocks Billionaire John Paulson Loves
GRFS,GRFS:UW,BBG001QMCL19,First Trust NYSE Arca Biotechnology Index Fund Experiences Big Outflow,2016-02-18 17:43:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QCsM6lUNYuc/first-trust-nyse-arca-biotechnology-index-fund-experiences-big-outflow-cm581566,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the First Trust NYSE Arca Biotechnology Index Fund (Symbol FBT) where we have detected an approximate $138.6"
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Advance as Pharmaceutical Firms Strengthen,2016-01-29 16:35:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KEgpqz1xwn8/european-adrs-advance-as-pharmaceutical-firms-strengthen-cm572176,"American depository receipts of European stocks were trading 0.4% stronger at 118.49 on the Bank of New York Mellon Europe ADR Index on Friday as pharmaceutical firms pulled higher. Gainers in Continental Europe included Cellectis ( CLLS ), a"
GRFS,GRFS:UW,BBG001QMCL19,"FBT, CRL, QGEN, GRFS: Large Outflows Detected at ETF",2016-01-27 17:20:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uVtljNY6BDc/fbt-crl-qgen-grfs-large-outflows-detected-at-etf-cm571002,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the First Trust NYSE Arca Biotechnology Index Fund (Symbol FBT) where we have detected an approximate $133.8"
GRFS,GRFS:UW,BBG001QMCL19,"Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV",2016-01-26 12:29:23 +0000,http://www.publicnow.com/view/2CF95E3BED255DEEE0CB7F88402F3C62FE1F99EC,"[at noodls] - AlbaJuna Therapeutics, a spin-off from the IrsiCaixa AIDS Research Institute, is developing a new treatment strategy based on monoclonal antibodies with great potential to neutralize HIV and activate the ..."
GRFS,GRFS:UW,BBG001QMCL19,"Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV Download (249.7 Kb)",2016-01-26 12:29:23 +0000,http://www.publicnow.com/view/3592391C813C4C62D5BD5278351D480493A046A8,"[at noodls] - 7521d9bd-d06f-4f66-938b-981d2dc65a49.pdf Grifols invests in the project led by AlbaJuna Therapeutics, a spin-­‐off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV AlbaJuna ..."
GRFS,GRFS:UW,BBG001QMCL19,Grifols Obtains Exclusive Rights to Market and Distribute MassBiologics' Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine in U.S.,2016-01-08 15:05:03 +0000,http://www.noodls.com/view/15E7D7B4A7ADCD34F44E5DC1B8BBA8D4DAFAFA8D,"[at noodls] - Grifols is the only company in the U.S. that offers two tetanus therapies, providing patients at risk for tetanus with both passive and active immunity Almost all cases of tetanus in the U.S. occur in ..."
GRFS,GRFS:UW,BBG001QMCL19,Spain's Upcoming Election Might Be Good News For Investors,2015-12-17 17:08:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nU7YNrJ-Sv0/spains-upcoming-election-might-be-good-news-for-investors-cm555866,"After writing earlier this year, several times, of the debacle that is, was, and will always be Greece, I had wondered if the contagion initiated by Syriza had spread to other politically precarious countries in the Eurozone. I looked at Portugal, and felt that they appeared to be doing okay and had swallowed the"
GRFS,GRFS:UW,BBG001QMCL19,Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company Download (22.3 Kb),2015-12-14 07:34:23 +0000,http://www.noodls.com/view/2347F83C33339A60A66EAE6430C0CFF4682B8D40,[at noodls] - np-20151214-en Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company From 1 January 2017 Victor Grifols Roura will ...
GRFS,GRFS:UW,BBG001QMCL19,Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company,2015-12-14 07:14:25 +0000,http://www.noodls.com/view/E485D7B3829D0C2E9047206BBB3D2700442AF59C,"[at noodls] - From 1 January 2017 Victor Grifols Roura will be succeeded by his brother, Raimon Grifols, and his son, Víctor Grifols Deu, who will become joint and several chief executive officers of the company. Víctor ..."
GRFS,GRFS:UW,BBG001QMCL19,"Pre-Market Most Active for Dec 2, 2015 :  VALE, YHOO, CPGX, ABEV, ZFGN, SUNE, BAC, XOM, AMSG, TVIX, XIV, GRFS",2015-12-02 14:07:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/23Ss4XDutIo/pre-market-most-active-for-dec-2-2015-vale-yhoo-cpgx-abev-zfgn-sune-bac-xom-amsg-tvix-xiv-grfs-cm549186,"The NASDAQ 100 Pre Market Indicator is up 2.18 to 4,718.34. The total Pre Market volume is currently 8,554,520 shares traded. The following are the most active stocks for the pre market session VALE S.A. ( VALE ) is"
GRFS,GRFS:UW,BBG001QMCL19,Inauguration of the Grifols Chair for the Study of Cirrhosis,2015-11-30 09:57:20 +0000,http://www.noodls.com/view/E6DF5942F1395505D71366484A493CA855E6AA3B,"[at noodls] - The Grifols Chair for the Study of Cirrhosis, a private chair with an international reach, was created to promote research and education on liver diseases, especially cirrhosis. The academic nature of ..."
GRFS,GRFS:UW,BBG001QMCL19,Grifols (GRFS): Moving Average Crossover Alert,2015-11-06 17:33:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oyp8EE8_WtQ/grifols-grfs-moving-average-crossover-alert-cm540026,"Are you a technical investor? If so, it may be time to consider Grifols, S.A.GRFS for your portfolio. The company just saw its 50 Day Moving Average breakout above its 200 Day Simple moving average, a trend that could"
GRFS,GRFS:UW,BBG001QMCL19,"Noteworthy ETF Outflows: FBT, MYGN, NKTR, GRFS",2015-09-30 15:58:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SY44iOBqlas/noteworthy-etf-outflows-fbt-mygn-nktr-grfs-cm525752,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the First Trust NYSE Arca Biotechnology Index Fund (Symbol FBT) where we have detected an approximate $53.9"
GRFS,GRFS:UW,BBG001QMCL19,GRFS Makes Bullish Cross Above Critical Moving Average,2015-09-16 17:14:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mZxRatLOjIU/grfs-makes-bullish-cross-above-critical-moving-average-cm520562,"In trading on Wednesday, shares of Grifols SA, Barcelona (Symbol GRFS) crossed above their 200 day moving average of $32.75, changing hands as high as $33.13 per share. Grifols SA, Barcelona shares are currently trading up about 1.6% on"
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Advance as Mining Stocks Extend Gains,2015-09-03 15:20:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ze9GptXcBk4/european-adrs-advance-as-mining-stocks-extend-gains-cm516476,"American depository receipts of European stocks were trading 0.9% higher at 131.64 on the Bank of New York Mellon Europe ADR Index on Thursday morning. Gainers in Continental Europe were led by Grifols ( GRFS ), a pharmaceutical and"
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Fractionally Higher as Pharmaceuticals Stocks Gain,2015-05-04 15:35:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tDGVH3HHFzE/european-adrs-fractionally-higher-as-pharmaceuticals-stocks-gain-cm472444,"American depository receipts of European stocks were trading 0.1% higher at 146.55 on the Bank of New York Mellon Europe ADR Index on Monday, helped by gains in pharmaceutical companies. Gainers in Continental Europe were led by pharmaceutical companies"
GRFS,GRFS:UW,BBG001QMCL19,European ADRs Gain as Manufacturing Activity Rises in Eurozone,2015-04-01 15:27:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3447Q-cqIQ0/european-adrs-gain-as-manufacturing-activity-rises-in-eurozone-cm461124,American depository receipts of European stocks were trading 0.5% higher at 140.57 on the Bank of New York Mellon Europe ADR Index on Wednesday after fresh data published by Markit Economics showed that growth of Eurozone manufacturing production accelerated
